Cargando…
Brazilian battle against COVID-19
The first coronavirus disease 2019 (COVID-19) report in Brazil occurs by the end of February, and 4 months later, there was more than 1 million infected patients and 54,971 deaths. The health-care system in Brazil is universal, meaning that all inhabitants are covered by the Unified Health Care Syst...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175629/ http://dx.doi.org/10.1016/B978-0-323-82860-4.00002-1 |
_version_ | 1783703082592370688 |
---|---|
author | Dias, Fernando Suparregui Rosa, Regis Goulart Mendes, Ciro Leite |
author_facet | Dias, Fernando Suparregui Rosa, Regis Goulart Mendes, Ciro Leite |
author_sort | Dias, Fernando Suparregui |
collection | PubMed |
description | The first coronavirus disease 2019 (COVID-19) report in Brazil occurs by the end of February, and 4 months later, there was more than 1 million infected patients and 54,971 deaths. The health-care system in Brazil is universal, meaning that all inhabitants are covered by the Unified Health Care System, and 20% of Brazilian citizens are covered by private health-care insurances. In this scenario, the government adopted some actions to combat the pandemics, including guidelines for COVID-19 prevention and management, allocation of funds to support primary care, extension of medical services in primary health units, increase in the number of health-care professionals, distribution of COVID-19 tests, use of telemedicine to monitor patients with flu-like symptoms, and teleconsulting with psychiatrist and psychologists. Since the pandemic offers a unique opportunity for research and management in Brazil, a coalition initiative conducted several therapeutic trials in search of safe treatments for patients with COVID-19. Other issue in this field was the organization of health system, both in private and public organizations. |
format | Online Article Text |
id | pubmed-8175629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-81756292021-06-04 Brazilian battle against COVID-19 Dias, Fernando Suparregui Rosa, Regis Goulart Mendes, Ciro Leite COVID-19 Pandemic Article The first coronavirus disease 2019 (COVID-19) report in Brazil occurs by the end of February, and 4 months later, there was more than 1 million infected patients and 54,971 deaths. The health-care system in Brazil is universal, meaning that all inhabitants are covered by the Unified Health Care System, and 20% of Brazilian citizens are covered by private health-care insurances. In this scenario, the government adopted some actions to combat the pandemics, including guidelines for COVID-19 prevention and management, allocation of funds to support primary care, extension of medical services in primary health units, increase in the number of health-care professionals, distribution of COVID-19 tests, use of telemedicine to monitor patients with flu-like symptoms, and teleconsulting with psychiatrist and psychologists. Since the pandemic offers a unique opportunity for research and management in Brazil, a coalition initiative conducted several therapeutic trials in search of safe treatments for patients with COVID-19. Other issue in this field was the organization of health system, both in private and public organizations. 2022 2021-06-04 /pmc/articles/PMC8175629/ http://dx.doi.org/10.1016/B978-0-323-82860-4.00002-1 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Dias, Fernando Suparregui Rosa, Regis Goulart Mendes, Ciro Leite Brazilian battle against COVID-19 |
title | Brazilian battle against COVID-19 |
title_full | Brazilian battle against COVID-19 |
title_fullStr | Brazilian battle against COVID-19 |
title_full_unstemmed | Brazilian battle against COVID-19 |
title_short | Brazilian battle against COVID-19 |
title_sort | brazilian battle against covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175629/ http://dx.doi.org/10.1016/B978-0-323-82860-4.00002-1 |
work_keys_str_mv | AT diasfernandosuparregui brazilianbattleagainstcovid19 AT rosaregisgoulart brazilianbattleagainstcovid19 AT mendesciroleite brazilianbattleagainstcovid19 |